Wegovy Pill vs Weight-Loss Shots: 7 Important Things to Know in 2026
New 2026 data followed people who switched from injectable GLP-1 weight-loss drugs to the Wegovy pill. Here’s what happened after three months — and what the study does not prove.
New 2026 data followed people who switched from injectable GLP-1 weight-loss drugs to the Wegovy pill. Here’s what happened after three months — and what the study does not prove.
Fresh 2026 research found nail detachment and discoloration were reported more often among GLP-1 users. Here are 7 important findings women should know.
A new clinical trial tested semaglutide in children aged 6 to under 12 with obesity. Here’s what the 68-week results showed, what they do not prove, and what families should know.